Cureus

Small Bowel Blockage Without Surgery in a Patient Taking Zepbound: A Case Report

Updated

Abstract

A 52-year-old woman developed a functional small bowel obstruction after a dose escalation of Zepbound.

  • The patient had no prior history of abdominal surgery or gastrointestinal interventions.
  • Functional small bowel obstruction occurred despite the absence of conventional risk factors.
  • Zepbound is a medication prescribed for weight loss that may be linked to gastrointestinal motility issues.
  • This case suggests a need for caution regarding potential severe gastrointestinal complications with Zepbound.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free